Glyoxalase 1 as a candidate for indicating the metastatic potential of SN12C human renal cell carcinoma cell clones

Tanaka,Toshiyuki; Kuramitsu,Yasuhiro; Wang,Yufeng; Baron,Byron; Kitagawa,Takao; Tokuda,Kazuhiro; Hirakawa,Kosei; Yashiro,Masakazu; Naito,Seiji; Nakamura,Kazuyuki

doi:10.3892/or.2013.2699

Glyoxalase 1 as a candidate for indicating the metastatic potential of SN12C human renal cell carcinoma cell clones

Authors:
- Toshiyuki Tanaka
- Yasuhiro Kuramitsu
- Yufeng Wang
- Byron Baron
- Takao Kitagawa
- Kazuhiro Tokuda
- Kosei Hirakawa
- Masakazu Yashiro
- Seiji Naito
- Kazuyuki Nakamura
View Affiliations

Affiliations: Department of Biochemistry and Functional Proteomics, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi 755-8505, Japan, Department of Surgical Oncology, Osaka City University, Graduate School of Medicine, Osaka 545‑8585, Japan, Department of Urology, Graduate School of Medical Sciences Kyushu University, Fukuoka 812-8582, Japan
Published online on: August 27, 2013 https://doi.org/10.3892/or.2013.2699
Pages: 2365-2370

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Three clones with differential metastatic potential were established from the parental SN12C human renal cell carcinoma (HRCC). We previously reported that in the two high metastatic SN12C clones, two isoforms of ubiquitin carboxyl-terminal hydrolase isozyme L1 (UCH‑L1) showed decreased expression by using two-dimensional electrophoresis (2‑DE) covering a pH range (pH 3.0‑10.0) followed by liquid chromatography‑tandem mass spectrometry. However, in the case of the low metastatic clone, the spot volume for UCH‑L1 was almost the same as for the parental SN12C. In the present study, we found one protein spot which was correlated with the metastatic potential of SN12C clones by using 2‑DE over a narrow pH range (pH 4.0‑7.0). The protein glyoxalase 1 (GLO1) appeared to be directly proportional to the metastatic potential of the SN12C clones. GLO1 was the only protein which consistently varied according to the metastatic potentials of SN12C clones. GLO1 was increased in high metastatic cell lines by western blot analysis. These findings suggest that GLO1 is associated with the metastatic potential of SN12C HRCC clones. We expanded our experimental range to include clones of scirrhous gastric cancer cell lines (OCUM‑2M, OCUM‑2D and OCUM‑2MLN) and similar results were obtained, thereby further strengthening our original findings.

View Figures

View References

1	Geiger TR and Peeper DS: Metastasis mechanisms. Biochim Biophys Acta. 1796:293–308. 2009.PubMed/NCBI
2	Fidler IJ: Models for spontaneous metastasis. Cancer Res. 66:97872006. View Article : Google Scholar : PubMed/NCBI
3	Naito S, von Eschenbach AC, Giavazzi R and Fidler IJ: Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice. Cancer Res. 46:4109–4115. 1986.PubMed/NCBI
4	Naito S, Walker SM, von Eschenbach AC and Fidler IJ: Evidence for metastatic heterogeneity of human renal cell carcinoma. Anticancer Res. 8:1163–1167. 1988.PubMed/NCBI
5	Naito S, Walker SM and Fidler IJ: In vivo selection of human renal cell carcinoma cells with high metastatic potential in nude mice. Clin Exp Metastasis. 7:381–389. 1989. View Article : Google Scholar : PubMed/NCBI
6	Tanaka T, Kuramitsu Y, Fujimoto M, Naito S, Oka M and Nakamura K: Downregulation of two isoforms of ubiquitin carboxyl-terminal hydrolase isozyme L1 correlates with high metastatic potentials of human SN12C renal cell carcinoma cell clones. Electolophoresis. 29:2651–2659. 2008. View Article : Google Scholar : PubMed/NCBI
7	Fidler IJ and Kripke ML: Metastasis results from preexisting variant cells within a malignant tumor. Science. 197:893–895. 1977. View Article : Google Scholar : PubMed/NCBI
8	Yashiro M, Chung YS, Nishimura S, Inoue T and Sowa M: Peritoneal metastatic model for human scirrhous gastric carcinoma in nude mice. Clin Exp Metastasis. 14:43–54. 1996. View Article : Google Scholar : PubMed/NCBI
9	Fujihara T, Sawada T, Hirakawa K, Chung YS, Yashiro M, Inoue T and Sowa M: Establishment of lymph node metastatic model for human gastric cancer in nude mice and analysis of factors associated with metastasis. Clin Exp Metastasis. 16:389–398. 1998. View Article : Google Scholar : PubMed/NCBI
10	Fukagawa Y, Nishikawa J, Kuramitsu Y, Iwakiri D, Takada K, Imai S, Satake M, et al: Epstein-Barr virus upregulates phosphorylated heat shock protein 27 kDa in carcinoma cells using the phosphoinositide 3-kinase/Akt pathway. Electrophoresis. 29:3192–3200. 2008.PubMed/NCBI
11	Mori-Iwamoto S, Kuramitsu Y, Ryozawa S, Taba K, Fujimoto M, Okita K, Nakamura K and Sakaida I: A proteomic profiling of gemcitabine resistance in pancreatic cancer cell lines. Mol Med Rep. 1:429–434. 2008.PubMed/NCBI
12	Mori-Iwamoto S, Kuramitsu Y, Ryozawa S, Mikuria K, Fujimoto M, Maehara S, Maehara Y, et al: Proteomics finding heat shock protein 27 as a biomarker for resistance of pancreatic cancer cells to gemcitabine. Int J Oncol. 31:1345–1350. 2007.PubMed/NCBI
13	Hayashi E, Kuramitsu Y, Okada F, Fujimoto M, Zhang X, Kobayashi M, Iizuka N, et al: Proteomic profiling for cancer progression: differential display analysis for the expression of intracellular proteins between regressive and progressive cancer cell lines. Proteomics. 5:1024–1032. 2005. View Article : Google Scholar
14	Kuramitsu Y, Miyamoto H, Tanaka T, Zhang X, Fujimoto M, Ueda K, Tanaka T, et al: Proteomic differential display analysis identified upregulated astrocytic phosphoprotein PEA-15 in human malignant pleural methothelioma cell lines. Proteomics. 9:5078–5089. 2009. View Article : Google Scholar
15	Tamesa M, Kuramitsu Y, Fujimoto M, Maeda N, Nagashima Y, Tanaka T, Yamamoto S, et al: Detection of autoantibodies against cyclophilin A and triosephosphate isomerase in sera from breast cancer patients by proteomic analysis. Electrophoresis. 30:2168–2181. 2009. View Article : Google Scholar : PubMed/NCBI
16	Takashima M, Kuramitsu Y, Yokoyama Y, Iizuka N, Harada T, Fujimoto M, Sakaida I, et al: Proteomic analysis of autoantibodies in patients with hepatocellular carcinoma. Proteomics. 6:3894–3900. 2006. View Article : Google Scholar : PubMed/NCBI
17	Takashima M, Kuramitsu Y, Yokoyama Y, Iizuka N, Fujimoto M, Nishisaka T, Okita K, Oka M and Nakamura K: Overexpression of alpha enolase in hepatitis C virus-related hepatocellular carcinoma: association with tumor progression as determined by proteomic analysis. Proteomics. 5:1686–1692. 2005. View Article : Google Scholar
18	Ding Q, Wu Z, Guo Y, Zhao C, Jia Y, Kong F, Chen B, et al: Proteome analysis of up-regulated proteins in the rat spinal cord induced by transection injury. Proteomics. 6:505–518. 2006. View Article : Google Scholar : PubMed/NCBI
19	Henschke P, Vorum H, Honoré B and Rice GE: Protein profiling the effects of in vitro hyperoxic exposure on fetal rabbit lung. Proteomics. 6:1957–1962. 2006. View Article : Google Scholar : PubMed/NCBI
20	Shinohara M, Thornalley PJ, Giardino I, Beisswenger P, Thorpe SR, Onorato J and Brownlee M: Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. J Clin Invest. 101:1142–1147. 1998. View Article : Google Scholar
21	Thornalley PJ: Glyoxalase I - structure, function and a critical role in the enzymatic defence against glycation. Biochem Soc Trans. 31:1343–1348. 2003. View Article : Google Scholar : PubMed/NCBI
22	Mitsumoto A, Kim KR, Oshima G, Kunimoto M, Okawa K, Iwamatsu A and Nakagawa Y: Glyoxalase I is a novel nitric oxide responsive protein. Biochem J. 3:837–844. 1999. View Article : Google Scholar : PubMed/NCBI
23	de Hemptinne V, Rondas D, Vandekerckhove J and Vancompernolle K: Tumour necrosis factor induces phosphorylation primarily of the nitric-oxide-responsive form of glyoxalase I. Biochem J. 407:121–128. 2007.PubMed/NCBI
24	de Hemptinne V, Rondas D, Toepoel M and Vancompernolle K: Phosphorylation on Thr-106 and NO-modification of glyoxalase I suppress the TNF-induced transcriptional activity of NF-kappaB. Mol Cell Biochem. 325:169–178. 2009.PubMed/NCBI
25	Van Herreweghe F, Mao J, Chaplen FW, Grooten J, Gevaert K, Vandekerckhove J and Vancompernolle K: Tumor necrosis factor-induced modulation of glyoxalase I activities through phosphorylation by PKA results in cell death and is accompanied by the formation of a specific methylglyoxal-derived AGE. Proc Natl Acad Sci USA. 99:949–954. 2002.
26	Cheng WL, Tsai MM, Tsai CY, Huang YH, Chen CY, Chi HC, et al: Glyoxalase-I is a novel prognosis factor associated with gastric cancer progression. PLoS One. 7:e343522012. View Article : Google Scholar : PubMed/NCBI
27	Wang Y, Kuramitsu Y, Ueno T, Suzuki N, Yoshino S, Izuka N, Akada J, et al: Glyoxalase I (GLO1) is up-regulated in pancreatic cancerous tissues compared with related non-cancerous tissues. Anticancer Res. 32:3219–3222. 2012.PubMed/NCBI
28	Fonseca-Sánchez MA, Rodríguez Cuevas S, Mendoza-Hernández G, Bautista-Piña V, Arechaga Ocampo E, Hidalgo Miranda A, Quintanar Jurado V, et al: Breast cancer proteomics reveals a positive correlation between glyoxalase 1 expression and high tumor grade. Int J Oncol. 41:670–680. 2012.PubMed/NCBI
29	Jones MB, Krutzsch H, Shu H, Zhao Y, Liotta LA, Kohn EC and Petricoin EF III: Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer. Proteomics. 2:76–84. 2002. View Article : Google Scholar : PubMed/NCBI
30	Santel T, Pflug G, Hemdan NY, Schäfer A, Hollenbach M, Buchold M, Hintersdorf A, et al: Curcumin inhibits glyoxalase 1: a possible link to its anti-inflammatory and anti-tumor activity. PLoS One. 3:e35082008. View Article : Google Scholar : PubMed/NCBI
31	Tsuruo T, Naito M, Tomida A, Fujita N, Mashima T, Sakamoto H and Haga N: Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal. Cancer Sci. 94:15–21. 2003. View Article : Google Scholar : PubMed/NCBI
32	Kawatani M, Okumura H, Honda K, Kanoh N, Muroi M, Dohmae N, Takami M, et al: The identification of an osteoclastogenesis inhibitor through the inhibition of glyoxalase I. Proc Natl Acad Sci USA. 105:11691–11696. 2008. View Article : Google Scholar : PubMed/NCBI
33	Imoto M: Isolation of novel GGPP synthase-inhibitor Gerfelin and evaluation of its activity. Bunshi, Chobunshi, Chokozotai Rikogaku Heisei 15 Nendo Kenkyu Seika Hokokusho Gakujutsu Furonthia. 597–656. 2004.(In Japanese).